Showing results (21-30 of 1,394) with videos related to
Sort By:
Pageof 140
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
2001 ASPET Otto Krayer Award Lecture. Molecular targets for antiviral agentsE De ClercqNucleic Acids Symposium Series|January 1, 1982
Design of nucleoside, oligonucleotide and polynucleotide analogues as antiviral agentsE De ClercqVerhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|June 28, 2006
Influenza virus inhibitors available for the chemotherapy and/or chemoprophylaxis of influenza virus infectionsE De ClercqVerhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|June 7, 2007
AIDS in the Third World: how to stop the HIV infection?E De ClercqInternational Journal of Immunopharmacology|January 1, 1991
Chemotherapy of the acquired immune deficiency syndrome (AIDS): non-nucleoside inhibitors of the human immunodeficiency virus type 1 reverse transcriptaseE De ClercqAntiviral Research|October 1, 1998
The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infectionE De ClercqMedicinal Research Reviews|May 1, 1993
HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptaseE De ClercqAntimicrobial Agents and Chemotherapy|August 1, 1984
Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsE de ClercqBiochemical Pharmacology|October 19, 2006
Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridgeE De ClercqThe Journal of Antimicrobial Chemotherapy|July 1, 1993
Antivirals for the treatment of herpesvirus infectionsE De ClercqPageof 140